Skip to content
AnthologyRX

Oral minoxidil

Help grow fuller hair with oral minoxidil, prescribed off-label for pattern hair loss.

Your treatment plan

From $19/month equivalent

$57 billed every 3 months3-month commitment$49 billed monthly also availableAll fees includedView plan details
  • Licensed clinicians
  • FDA-approved generic medication
  • No clinic visit

Questions before you start?

Compare this treatment

What will I pay?

Standard plan price$19 per month equivalent, billed $57 every 3 months. 3-month commitment.

Billing options and renewal

The standard Minoxidil price is $49 billed monthly, or $57 paid up front every three months ($19 per month equivalent; a three-month commitment). These are recurring prices before any eligible first-order discount. A first-order offer reduces that order only; renewal uses the standard price for the chosen plan. A monthly equivalent is not a monthly charge.

View full plan details

What should I know about this treatment?

Help grow fuller hair with oral minoxidil, prescribed off-label for pattern hair loss.

Read the evidence and its limitations

What should I review before starting?

Boxed warning

The FDA-approved labeling for oral minoxidil covers its use as a blood-pressure medication and carries a boxed warning about fluid collecting around the heart, which can progress to tamponade, and about angina becoming worse.

A licensed clinician reviews your health history and medications and determines whether treatment is appropriate for you.

Read the full Important Safety Information

How do I request Minoxidil online?

Complete the online assessment with your health history, current medications and treatment goals. A licensed clinician reviews the information and decides whether to prescribe. If prescribed, a licensed pharmacy prepares and ships your medication.

See how care works
What It Is

The familiar hair molecule, from the inside.

Minoxidil is the active ingredient people know from topical hair-loss products. Oral treatment keeps the same molecule and changes the route completely: one tablet instead of a daily scalp application.

That route is the reason to consider the oral form.

Minoxidil began as a blood-pressure medication, which is why cardiovascular history matters. The molecule acts systemically, so blood pressure, heart history, swelling, and medication interactions remain part of the prescribing decision even when hair is the treatment goal.

For the right candidate, the practical advantage is obvious. No liquid, no drying time, no residue, no styling around an application. The treatment becomes one medication habit rather than a hair-care ritual.

One tablet replaces a daily topical routine. Cardiovascular screening and the months-long treatment horizon stay part of the same decision.

Read the evidence
Who It's For

For people who quit the routine before they quit the idea.

01

The Topical-Fatigued

You know minoxidil. What you dislike is the liquid, the drying time, the residue, and having to organize hair styling around treatment. You want to ask whether the oral route is medically reasonable.

02

The Adherence Realist

You have learned that a theoretically perfect regimen is useless if you stop doing it. One tablet fits your life better than a scalp application you already know you will resent.

03

The Cardiovascular-Screened Patient

You understand that oral minoxidil is not a casual route swap. Blood pressure and cardiovascular history belong in the decision, and you want someone qualified making that call.

Oral minoxidil is FDA-approved for high blood pressure and is prescribed off-label at low doses for hair loss. A licensed provider reviews your cardiovascular history and determines candidacy, and results vary.

This might not be the right fit if:
  • Known cardiovascular conditions, without provider clearance
  • Uncontrolled low or fluctuating blood pressure
  • Known hypersensitivity to minoxidil
  • Pregnancy or breastfeeding, unless specifically cleared by your provider
  • A tendency toward fluid retention or swelling that has not been evaluated

Your intake screens for all contraindications. Every candidate is evaluated by a licensed clinician before any prescription is issued. No prescription is issued without clearance.

Your Plan

Minoxidil, prescribed with care.

FDA-approved generic medication. Prescribed by a licensed provider after clinical review.

One price covers your consultation, provider review, medication if prescribed, pharmacy fulfillment, shipping and follow-up. All fees included.
Format
Oral tablet
Strength
2.5 mg
Total plan quantity
90 tablets
Billed amount
$57 every 3 months
Monthly equivalent
$19 per month
Commitment
3 months
Monthly option
$49 billed monthly · 30 tablets total plan quantity
Fees
Included in the plan price

Strength describes the preparation. Total plan quantity is the amount included in that plan, not your dose or dosing schedule. Follow the directions on your prescription.

Your subscription renews at your selected billing interval. Cancel through your member dashboard before the next billing date to stop future charges. Cancellation does not refund the current billing period. See cancellation and refund terms.

Have a question about this plan?

Billing

Our support team can help with plan prices, billing and portal access.

Ask about billing

Shipping

Contact AnthologyRX support for help checking a shipment.

Get shipment help

Clinical questions

Message your provider about dosing, side effects, your response or changes in your health.

Open patient portal

New to AnthologyRX? Ask our team about getting started.

The people behind your care

Guidance from the first question onward.

Independent clinical care

Licensed clinicians affiliated with Arora Health & Aesthetics, LLC review your health history, medications and goals, then discuss whether Minoxidil or another approach fits your needs.

Medical information on this page reviewed by Dr. Dylan Russell, MD, Chief Health Officer on . Your prescribing clinician provides your individual care.

Verify Dr. Russell's medical license

Prescription pharmacy care

Minoxidil is offered as an FDA-approved generic medication, dispensed by a licensed pharmacy after your clinician issues a prescription.

Your clinician explains the intended use, including whether it falls outside the medication's FDA-approved indications.

Pharmacy & fulfillment

Listed dispensing pharmacy

Availability depends on your prescription and location. For pharmacy questions, contact our team.

Explore our pharmacy quality standards

A direct line for follow-up

Message your provider through the patient portal about dosing, side effects, your response or changes in your health. Contact AnthologyRX support for billing, shipment or portal-access help.

The Evidence

What the research shows

Randomized · double-blind · double-dummy · 90 men · 24 weeks

Oral minoxidil did not beat topical minoxidil on hair density at the scalp or vertex.

49 percent
hypertrichosis reported in the oral group
The detail

In a 24-week double-blind, double-dummy randomized clinical trial in 90 men aged 18 to 55 with androgenetic alopecia, of whom 68 completed, oral minoxidil 5 mg once daily did not demonstrate superiority over topical minoxidil 5 percent twice daily for terminal hair density at the frontal scalp or the vertex; photographic analysis favored oral minoxidil at the vertex by 24 percent, 95 percent confidence interval 0 to 48, and hypertrichosis was reported in 49 percent of the oral group.1

Triple-blind randomized · 72 women · 9 months

In women, oral and topical minoxidil both increased hair diameter and density, with no difference between them.

0.25 mg
daily oral dose, tested against topical minoxidil 2 percent
The detail

In a 9-month triple-blind randomized clinical trial in 72 women with female pattern hair loss, oral minoxidil 0.25 mg daily and topical minoxidil 2 percent each significantly increased average hair diameter and hair density from their own baselines, and the difference between the two treatments was not statistically significant.2

Meta-analysis · four randomized trials · 279 patients

Pooled trials found no difference in hair density, but more hypertrichosis on the oral form.

2.01
risk ratio for hypertrichosis, oral versus topical
The detail

In a meta-analysis of four randomized clinical trials covering 279 patients with androgenetic alopecia followed for 24 to 39 weeks, oral and topical minoxidil did not differ in hair density or hair diameter, while hypertrichosis was significantly more common with the oral form, risk ratio 2.01, 95 percent confidence interval 1.18 to 3.41.3

Retrospective multicenter review · 1404 patients · no control group

Hypertrichosis was the most frequent effect; no life-threatening effects were observed.

15.1 percent
hypertrichosis rate in 1404 patients on low-dose oral minoxidil
The detail

In a retrospective multicenter study of 1404 patients treated with low-dose oral minoxidil for at least three months for any type of alopecia, the most frequent adverse effect was hypertrichosis at 15.1 percent, systemic effects included lightheadedness at 1.7 percent, fluid retention at 1.3 percent and tachycardia at 0.9 percent, 1.2 percent of patients stopped the drug because of adverse effects, and no life-threatening adverse effects were observed. The study had no control group.4

Randomized · double-blind · placebo-controlled · 393 men · 48 weeks

The topical comparator itself beat placebo on hair count and scalp coverage ratings.

393 men · 48 weeks
topical minoxidil 5 percent against 2 percent and placebo vehicle
The detail

The comparator in those trials is itself well supported: in a 48-week double-blind, placebo-controlled, randomized multicenter trial in 393 men aged 18 to 49, topical minoxidil 5 percent was superior to both topical minoxidil 2 percent and placebo vehicle for change in nonvellus hair count and for patient and investigator ratings of scalp coverage.5

What it does not show

Approved labeling

Hair loss is an off-label use; the safety database was built at blood-pressure doses.

The detail

The molecule is FDA-approved; this use of it is not. The approved labeling for minoxidil tablets covers hypertension that is symptomatic or associated with target organ damage and not manageable with a diuretic plus two other antihypertensive drugs, and it carries a boxed warning about pericardial effusion progressing to tamponade and about exacerbation of angina. Hair loss is an off-label use, and the labeled safety database was built at blood-pressure doses rather than the much lower doses used for hair.6

Trial design

No randomized trial has compared oral minoxidil with an inactive control.

The detail

No randomized trial has compared oral minoxidil with an inactive control for pattern hair loss. The randomized comparisons place it against topical minoxidil in double-dummy designs, so what they establish is that the oral route is not clearly better or worse than the topical one, not the size of the effect against no treatment at all.123

Duration

Nothing published covers years of continuous use at hair-loss doses.

24 to 39 weeks
longest randomized follow-up published
The detail

The randomized follow-up runs 24 to 39 weeks and the largest safety dataset is a retrospective chart review with no control group. Nothing published establishes efficacy or cardiovascular safety across years of continuous use at hair-loss doses, which is the horizon on which this treatment is actually taken.34

Applicability

Nothing here shows the oral route grows more hair than the topical route.

The detail

Nothing here shows the oral route grows more hair than the topical route. Where the trials did find a difference, it was hypertrichosis reported more often on the oral form. The case for the tablet rests on route and adherence, not on a demonstrated efficacy advantage.13

  1. Penha MA, Miot HA, Kasprzak M, Muller Ramos P. Oral minoxidil vs topical minoxidil for male androgenetic alopecia: a… JAMA Dermatol. 2024.
  2. Vahabi-Amlashi S, et al. A randomized clinical trial on therapeutic effects of 0.25 mg oral… Dermatol Ther. 2021.
  3. Sobral MVS, et al. Efficacy and safety of oral minoxidil versus topical solution in… Int J Dermatol. 2025.
  4. Vano-Galvan S, et al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of… J Am Acad Dermatol. 2021.
  5. Olsen EA, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical… J Am Acad Dermatol. 2002.
  6. FDA-approved prescribing information, minoxidil tablets USP (oral), Par Health USA LLC, label published June 2026.DailyMed
Important Safety Information
Boxed warning

The FDA-approved labeling for oral minoxidil covers its use as a blood-pressure medication and carries a boxed warning about fluid collecting around the heart, which can progress to tamponade, and about angina becoming worse.

Do not use if you have

  • Pheochromocytoma

Serious risks

  • Fluid retention with swelling or rapid weight gain
  • A faster heart rate and lightheadedness

Commonly reported

  • The effect people report most often: hair growing where they did not want it, on the face, arms or body
  • The labeling describes that change appearing within three to six weeks of starting and taking one to six months to fade after stopping

Your provider reviews cardiovascular history, blood pressure and current medications closely. The molecule is FDA-approved and this use of it for hair is not, which is exactly why the decision sits with a clinician rather than in a shopping cart.

Questions

Asked and answered.

Explore

More in Beauty & Skin.

AnthologyRX
Find your treatment
Browse all treatments